Premenstrual syndrome (PMS/PMDD)

Exam relevance: in 1 of more than 150 board exam reports · rank 171

Synonyms
PMS, premenstrual syndrome, PMDD
Specialty
Gynaecology · Endocrinology & cycle
Exam relevance
1 of more than 150 reports · rank 171
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Definition
  2. Occurrence & epidemiology
  3. Aetiopathogenesis
  4. Clinical features
  5. Diagnosis
  6. Treatment principles
  7. Keep learning in the app
  8. Further reading (selection)
  9. Cross-references

Definition

  • Premenstrual syndrome comprises mood, behavioural and physical symptoms that begin in the luteal phase about 1 to 2 weeks before menstruation and resolve shortly after bleeding starts.
  • Premenstrual dysphoric disorder is the most severe form and is classified among the depressive disorders in DSM-5.

Occurrence & epidemiology

Epidemiology

  • Most women of reproductive age experience at most mild premenstrual discomfort; 5–8% develop moderate to severe symptoms with significant impairment.
  • The prevalence of PMDD among women of reproductive age in the United States is given as about 2–6%; global estimates vary widely.

Aetiopathogenesis

Aetiology and pathogenesis

  • The cause is unclear; an individually increased sensitivity to normal cyclical hormonal fluctuations is assumed, involving progesterone metabolites such as allopregnanolone and the GABAergic and serotonergic systems.

Clinical features

  • Physical symptoms include breast tenderness, headache, joint or muscle pain, bloating and weight gain.
  • Core psychological symptoms are depressed mood, anxiety and tension, affective lability and irritability or anger; irritability is among the most common symptoms.

Diagnosis

  • For PMDD, DSM-5 requires at least 5 of 11 symptoms, including at least 1 of the 4 core symptoms, in most menstrual cycles of the preceding year.
  • Symptoms occur in the final week before menstruation and resolve in the week after; this is confirmed by prospective daily symptom ratings over at least 2 consecutive cycles.

Treatment principles

  • The foundation is education, a symptom diary to confirm the diagnosis, lifestyle measures and cognitive behavioural therapy.
  • For marked symptoms, and particularly in premenstrual dysphoric disorder, selective serotonin reuptake inhibitors are effective, given continuously or in the luteal phase only; ovulation-suppressing contraceptives are an alternative.
  • In severe refractory cases, ovarian suppression with GnRH analogues plus hormonal add-back therapy may be considered.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Premenstrual syndrome (PMS/PMDD) with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Premenstrual Disorders (NCBI Bookshelf)
  2. MSD Manual Professional: Premenstrual Syndrome (PMS)
  3. Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Precocious and delayed puberty · Female infertility · Turner syndrome

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.